Open access · US-GOV via ClinicalTrials.gov Clinical trial

Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach

Authors not listed

Icahn School of Medicine at Mount Sinai · 2019

Loss of proteostasis Human Randomized controlled trial

Abstract

To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-11-01 MST

Cite this

APA

Anonymous. (2019). Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach. <em>Icahn School of Medicine at Mount Sinai</em>. https://clinicaltrials.gov/study/NCT03933696

Vancouver

Anonymous. Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach. Icahn School of Medicine at Mount Sinai. 2019.

BibTeX

@misc{anon2019LightM, title = {Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach}, author = {Anonymous}, journal = {Icahn School of Medicine at Mount Sinai}, year = {2019}, }